APO Research
Talk to an analyst

APO RESEARCH · REPORT

Targeted Genome Analysis Kits

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Targeted Genome Analysis Kits Market Outlook and Growth Opportunities 2026

27 December 2025192 pages

Choose your research edition.

Industry ResearchTargeted Genome Analysis Kits Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Targeted Genome Analysis Kits Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Targeted Genome Analysis Kits Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Targeted Genome Analysis Kits Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Targeted Genome Analysis Kits Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Targeted Genome Analysis Kits market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Targeted Genome Analysis Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Targeted Genome Analysis Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Targeted Genome Analysis Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Targeted Genome Analysis Kits market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Targeted Genome Analysis Kits market include Singleron, Thermo Fisher Scientific, Mole Bioscience, BGI, Illumina, Daicel Arbor Biosciences, BD, Agilent and Agena Bioscience, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Targeted Genome Analysis Kits market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Targeted Genome Analysis Kits and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Targeted Genome Analysis Kits sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Targeted Genome Analysis Kits market size, projected growth trends, production technologies, key applications, and end-use industries.

Targeted Genome Analysis Kits Segment by Company

Singleron

Thermo Fisher Scientific

Mole Bioscience

BGI

Illumina

Daicel Arbor Biosciences

BD

Agilent

Agena Bioscience

Targeted Genome Analysis Kits Segment by Type

PCR-based Targeted Kits

NGS (Next Generation Sequencing)-based Targeted Kits

Other

Targeted Genome Analysis Kits Segment by Application

Hospital

Laboratory

Other

Targeted Genome Analysis Kits Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Targeted Genome Analysis Kits status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Targeted Genome Analysis Kits market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Targeted Genome Analysis Kits significant trends, drivers, influence factors in global and regions.

6. To analyze Targeted Genome Analysis Kits competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Targeted Genome Analysis Kits market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Targeted Genome Analysis Kits and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Targeted Genome Analysis Kits.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Targeted Genome Analysis Kits market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Targeted Genome Analysis Kits industry.

Chapter 3: Detailed analysis of Targeted Genome Analysis Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Targeted Genome Analysis Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Targeted Genome Analysis Kits in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Targeted Genome Analysis Kits Industry Trends Table 2. Targeted Genome Analysis Kits Industry Drivers Table 3. Targeted Genome Analysis Kits Industry Opportunities and Challenges Table 4. Targeted Genome Analysis Kits Industry Restraints Table 5. Global Targeted Genome Analysis Kits Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Targeted Genome Analysis Kits Revenue Share by Company (2021-2026) Table 7. Global Targeted Genome Analysis Kits Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Targeted Genome Analysis Kits Sales Volume Share by Company (2021-2026) Table 9. Global Targeted Genome Analysis Kits Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Targeted Genome Analysis Kits Company Ranking, (2024-2026) & (USD Million) Table 11. Global Targeted Genome Analysis Kits Key Company Manufacturing Base & Headquarters Table 12. Global Targeted Genome Analysis Kits Company, Product Type & Application Table 13. Global Targeted Genome Analysis Kits Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Targeted Genome Analysis Kits by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of PCR-based Targeted Kits Table 18. Significant Companies of NGS (Next Generation Sequencing)-based Targeted Kits Table 19. Significant Companies of Other Table 20. Global Targeted Genome Analysis Kits Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Targeted Genome Analysis Kits Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Targeted Genome Analysis Kits Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Targeted Genome Analysis Kits Sales Volume Share by Type (2021-2026) Table 24. Global Targeted Genome Analysis Kits Sales Volume Share by Type (2027-2032) Table 25. Global Targeted Genome Analysis Kits Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Targeted Genome Analysis Kits Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Targeted Genome Analysis Kits Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Targeted Genome Analysis Kits Sales Value Share by Type (2021-2026) Table 29. Global Targeted Genome Analysis Kits Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Laboratory Table 32. Significant Companies of Other Table 33. Global Targeted Genome Analysis Kits Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Targeted Genome Analysis Kits Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Targeted Genome Analysis Kits Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Targeted Genome Analysis Kits Sales Volume Share by Application (2021-2026) Table 37. Global Targeted Genome Analysis Kits Sales Volume Share by Application (2027-2032) Table 38. Global Targeted Genome Analysis Kits Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Targeted Genome Analysis Kits Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Targeted Genome Analysis Kits Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Targeted Genome Analysis Kits Sales Value Share by Application (2021-2026) Table 42. Global Targeted Genome Analysis Kits Sales Value Share by Application (2027-2032) Table 43. Global Targeted Genome Analysis Kits Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Targeted Genome Analysis Kits Sales by Region (2021-2026) & (K Units) Table 45. Global Targeted Genome Analysis Kits Sales Market Share by Region (2021-2026) Table 46. Global Targeted Genome Analysis Kits Sales by Region (2027-2032) & (K Units) Table 47. Global Targeted Genome Analysis Kits Sales Market Share by Region (2027-2032) Table 48. Global Targeted Genome Analysis Kits Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Targeted Genome Analysis Kits Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Targeted Genome Analysis Kits Sales Value Share by Region (2021-2026) Table 51. Global Targeted Genome Analysis Kits Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Targeted Genome Analysis Kits Sales Value Share by Region (2027-2032) Table 53. Global Targeted Genome Analysis Kits Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Targeted Genome Analysis Kits Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Targeted Genome Analysis Kits Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Targeted Genome Analysis Kits Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Targeted Genome Analysis Kits Sales by Country (2021-2026) & (K Units) Table 58. Global Targeted Genome Analysis Kits Sales Market Share by Country (2021-2026) Table 59. Global Targeted Genome Analysis Kits Sales by Country (2027-2032) & (K Units) Table 60. Global Targeted Genome Analysis Kits Sales Market Share by Country (2027-2032) Table 61. Global Targeted Genome Analysis Kits Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Targeted Genome Analysis Kits Sales Value Market Share by Country (2021-2026) Table 63. Global Targeted Genome Analysis Kits Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Targeted Genome Analysis Kits Sales Value Market Share by Country (2027-2032) Table 65. Singleron Company Information Table 66. Singleron Business Overview Table 67. Singleron Targeted Genome Analysis Kits Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Singleron Targeted Genome Analysis Kits Product Portfolio Table 69. Singleron Recent Development Table 70. Thermo Fisher Scientific Company Information Table 71. Thermo Fisher Scientific Business Overview Table 72. Thermo Fisher Scientific Targeted Genome Analysis Kits Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Thermo Fisher Scientific Targeted Genome Analysis Kits Product Portfolio Table 74. Thermo Fisher Scientific Recent Development Table 75. Mole Bioscience Company Information Table 76. Mole Bioscience Business Overview Table 77. Mole Bioscience Targeted Genome Analysis Kits Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Mole Bioscience Targeted Genome Analysis Kits Product Portfolio Table 79. Mole Bioscience Recent Development Table 80. BGI Company Information Table 81. BGI Business Overview Table 82. BGI Targeted Genome Analysis Kits Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. BGI Targeted Genome Analysis Kits Product Portfolio Table 84. BGI Recent Development Table 85. Illumina Company Information Table 86. Illumina Business Overview Table 87. Illumina Targeted Genome Analysis Kits Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Illumina Targeted Genome Analysis Kits Product Portfolio Table 89. Illumina Recent Development Table 90. Daicel Arbor Biosciences Company Information Table 91. Daicel Arbor Biosciences Business Overview Table 92. Daicel Arbor Biosciences Targeted Genome Analysis Kits Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Daicel Arbor Biosciences Targeted Genome Analysis Kits Product Portfolio Table 94. Daicel Arbor Biosciences Recent Development Table 95. BD Company Information Table 96. BD Business Overview Table 97. BD Targeted Genome Analysis Kits Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. BD Targeted Genome Analysis Kits Product Portfolio Table 99. BD Recent Development Table 100. Agilent Company Information Table 101. Agilent Business Overview Table 102. Agilent Targeted Genome Analysis Kits Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Agilent Targeted Genome Analysis Kits Product Portfolio Table 104. Agilent Recent Development Table 105. Agena Bioscience Company Information Table 106. Agena Bioscience Business Overview Table 107. Agena Bioscience Targeted Genome Analysis Kits Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Agena Bioscience Targeted Genome Analysis Kits Product Portfolio Table 109. Agena Bioscience Recent Development Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. Targeted Genome Analysis Kits Distributors List Table 113. Targeted Genome Analysis Kits Customers List Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Targeted Genome Analysis Kits Product Image Figure 2. Global Targeted Genome Analysis Kits Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Targeted Genome Analysis Kits Sales Value (2021-2032) & (US$ Million) Figure 4. Global Targeted Genome Analysis Kits Sales (2021-2032) & (K Units) Figure 5. Global Targeted Genome Analysis Kits Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Targeted Genome Analysis Kits Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. PCR-based Targeted Kits Image Figure 10. NGS (Next Generation Sequencing)-based Targeted Kits Image Figure 11. Other Image Figure 12. Global Targeted Genome Analysis Kits Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Targeted Genome Analysis Kits Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Targeted Genome Analysis Kits Sales Volume Share by Type (2021-2032) Figure 15. Global Targeted Genome Analysis Kits Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Targeted Genome Analysis Kits Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Targeted Genome Analysis Kits Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Laboratory Image Figure 20. Other Image Figure 21. Global Targeted Genome Analysis Kits Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Targeted Genome Analysis Kits Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Targeted Genome Analysis Kits Sales Volume Share by Application (2021-2032) Figure 24. Global Targeted Genome Analysis Kits Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Targeted Genome Analysis Kits Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Targeted Genome Analysis Kits Sales Value Share by Application (2021-2032) Figure 27. Global Targeted Genome Analysis Kits Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Targeted Genome Analysis Kits Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Targeted Genome Analysis Kits Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Targeted Genome Analysis Kits Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Targeted Genome Analysis Kits Sales Value (2021-2032) & (US$ Million) Figure 32. North America Targeted Genome Analysis Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Targeted Genome Analysis Kits Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Targeted Genome Analysis Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Targeted Genome Analysis Kits Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Targeted Genome Analysis Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Targeted Genome Analysis Kits Sales Value (2021-2032) & (US$ Million) Figure 38. South America Targeted Genome Analysis Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Targeted Genome Analysis Kits Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Targeted Genome Analysis Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Targeted Genome Analysis Kits Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Targeted Genome Analysis Kits Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • PCR-based Targeted Kits
  • NGS (Next Generation Sequencing)-based Targeted Kits
  • Other
Applications
  • Hospital
  • Laboratory
  • Other
Companies covered
  • Singleron
  • Thermo Fisher Scientific
  • Mole Bioscience
  • BGI
  • Illumina
  • Daicel Arbor Biosciences
  • BD
  • Agilent
  • Agena Bioscience

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Targeted Genome Analysis Kits Sales Value (2021-2032)
  4. 1.2.2 Global Targeted Genome Analysis Kits Sales Volume (2021-2032)
  5. 1.2.3 Global Targeted Genome Analysis Kits Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Targeted Genome Analysis Kits Market Dynamics
  1. 2.1 Targeted Genome Analysis Kits Industry Trends
  2. 2.2 Targeted Genome Analysis Kits Industry Drivers
  3. 2.3 Targeted Genome Analysis Kits Industry Opportunities and Challenges
  4. 2.4 Targeted Genome Analysis Kits Industry Restraints
3 Targeted Genome Analysis Kits Market by Company
  1. 3.1 Global Targeted Genome Analysis Kits Company Revenue Ranking in 2025
  2. 3.2 Global Targeted Genome Analysis Kits Revenue by Company (2021-2026)
  3. 3.3 Global Targeted Genome Analysis Kits Sales Volume by Company (2021-2026)
  4. 3.4 Global Targeted Genome Analysis Kits Average Price by Company (2021-2026)
  5. 3.5 Global Targeted Genome Analysis Kits Company Ranking (2024-2026)
  6. 3.6 Global Targeted Genome Analysis Kits Company Manufacturing Base and Headquarters
  7. 3.7 Global Targeted Genome Analysis Kits Company Product Type and Application
  8. 3.8 Global Targeted Genome Analysis Kits Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Targeted Genome Analysis Kits Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Targeted Genome Analysis Kits Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Targeted Genome Analysis Kits Market by Type
  1. 4.1 Targeted Genome Analysis Kits Type Introduction
  2. 4.1.1 PCR-based Targeted Kits
  3. 4.1.2 NGS (Next Generation Sequencing)-based Targeted Kits
  4. 4.1.3 Other
  5. 4.2 Global Targeted Genome Analysis Kits Sales Volume by Type
  6. 4.2.1 Global Targeted Genome Analysis Kits Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Targeted Genome Analysis Kits Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Targeted Genome Analysis Kits Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Targeted Genome Analysis Kits Sales Value by Type
  10. 4.3.1 Global Targeted Genome Analysis Kits Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Targeted Genome Analysis Kits Sales Value by Type (2021-2032)
  12. 4.3.3 Global Targeted Genome Analysis Kits Sales Value Share by Type (2021-2032)
5 Targeted Genome Analysis Kits Market by Application
  1. 5.1 Targeted Genome Analysis Kits Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Laboratory
  4. 5.1.3 Other
  5. 5.2 Global Targeted Genome Analysis Kits Sales Volume by Application
  6. 5.2.1 Global Targeted Genome Analysis Kits Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Targeted Genome Analysis Kits Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Targeted Genome Analysis Kits Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Targeted Genome Analysis Kits Sales Value by Application
  10. 5.3.1 Global Targeted Genome Analysis Kits Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Targeted Genome Analysis Kits Sales Value by Application (2021-2032)
  12. 5.3.3 Global Targeted Genome Analysis Kits Sales Value Share by Application (2021-2032)
6 Targeted Genome Analysis Kits Regional Sales and Value Analysis
  1. 6.1 Global Targeted Genome Analysis Kits Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Targeted Genome Analysis Kits Sales by Region (2021-2032)
  3. 6.2.1 Global Targeted Genome Analysis Kits Sales by Region: 2021-2026
  4. 6.2.2 Global Targeted Genome Analysis Kits Sales by Region (2027-2032)
  5. 6.3 Global Targeted Genome Analysis Kits Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Targeted Genome Analysis Kits Sales Value by Region (2021-2032)
  7. 6.4.1 Global Targeted Genome Analysis Kits Sales Value by Region: 2021-2026
  8. 6.4.2 Global Targeted Genome Analysis Kits Sales Value by Region (2027-2032)
  9. 6.5 Global Targeted Genome Analysis Kits Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Targeted Genome Analysis Kits Sales Value (2021-2032)
  12. 6.6.2 North America Targeted Genome Analysis Kits Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Targeted Genome Analysis Kits Sales Value (2021-2032)
  15. 6.7.2 Europe Targeted Genome Analysis Kits Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Targeted Genome Analysis Kits Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Targeted Genome Analysis Kits Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Targeted Genome Analysis Kits Sales Value (2021-2032)
  21. 6.9.2 South America Targeted Genome Analysis Kits Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Targeted Genome Analysis Kits Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Targeted Genome Analysis Kits Sales Value Share by Country, 2025 VS 2032
7 Targeted Genome Analysis Kits Country-level Sales and Value Analysis
  1. 7.1 Global Targeted Genome Analysis Kits Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Targeted Genome Analysis Kits Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Targeted Genome Analysis Kits Sales by Country (2021-2032)
  4. 7.3.1 Global Targeted Genome Analysis Kits Sales by Country (2021-2026)
  5. 7.3.2 Global Targeted Genome Analysis Kits Sales by Country (2027-2032)
  6. 7.4 Global Targeted Genome Analysis Kits Sales Value by Country (2021-2032)
  7. 7.4.1 Global Targeted Genome Analysis Kits Sales Value by Country (2021-2026)
  8. 7.4.2 Global Targeted Genome Analysis Kits Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Targeted Genome Analysis Kits Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Targeted Genome Analysis Kits Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Targeted Genome Analysis Kits Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Singleron
  2. 8.1.1 Singleron Company Information
  3. 8.1.2 Singleron Business Overview
  4. 8.1.3 Singleron Targeted Genome Analysis Kits Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Singleron Targeted Genome Analysis Kits Product Portfolio
  6. 8.1.5 Singleron Recent Developments
  7. 8.2 Thermo Fisher Scientific
  8. 8.2.1 Thermo Fisher Scientific Company Information
  9. 8.2.2 Thermo Fisher Scientific Business Overview
  10. 8.2.3 Thermo Fisher Scientific Targeted Genome Analysis Kits Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Scientific Targeted Genome Analysis Kits Product Portfolio
  12. 8.2.5 Thermo Fisher Scientific Recent Developments
  13. 8.3 Mole Bioscience
  14. 8.3.1 Mole Bioscience Company Information
  15. 8.3.2 Mole Bioscience Business Overview
  16. 8.3.3 Mole Bioscience Targeted Genome Analysis Kits Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Mole Bioscience Targeted Genome Analysis Kits Product Portfolio
  18. 8.3.5 Mole Bioscience Recent Developments
  19. 8.4 BGI
  20. 8.4.1 BGI Company Information
  21. 8.4.2 BGI Business Overview
  22. 8.4.3 BGI Targeted Genome Analysis Kits Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 BGI Targeted Genome Analysis Kits Product Portfolio
  24. 8.4.5 BGI Recent Developments
  25. 8.5 Illumina
  26. 8.5.1 Illumina Company Information
  27. 8.5.2 Illumina Business Overview
  28. 8.5.3 Illumina Targeted Genome Analysis Kits Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Illumina Targeted Genome Analysis Kits Product Portfolio
  30. 8.5.5 Illumina Recent Developments
  31. 8.6 Daicel Arbor Biosciences
  32. 8.6.1 Daicel Arbor Biosciences Company Information
  33. 8.6.2 Daicel Arbor Biosciences Business Overview
  34. 8.6.3 Daicel Arbor Biosciences Targeted Genome Analysis Kits Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Daicel Arbor Biosciences Targeted Genome Analysis Kits Product Portfolio
  36. 8.6.5 Daicel Arbor Biosciences Recent Developments
  37. 8.7 BD
  38. 8.7.1 BD Company Information
  39. 8.7.2 BD Business Overview
  40. 8.7.3 BD Targeted Genome Analysis Kits Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 BD Targeted Genome Analysis Kits Product Portfolio
  42. 8.7.5 BD Recent Developments
  43. 8.8 Agilent
  44. 8.8.1 Agilent Company Information
  45. 8.8.2 Agilent Business Overview
  46. 8.8.3 Agilent Targeted Genome Analysis Kits Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Agilent Targeted Genome Analysis Kits Product Portfolio
  48. 8.8.5 Agilent Recent Developments
  49. 8.9 Agena Bioscience
  50. 8.9.1 Agena Bioscience Company Information
  51. 8.9.2 Agena Bioscience Business Overview
  52. 8.9.3 Agena Bioscience Targeted Genome Analysis Kits Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Agena Bioscience Targeted Genome Analysis Kits Product Portfolio
  54. 8.9.5 Agena Bioscience Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Targeted Genome Analysis Kits Value Chain Analysis
  2. 9.1.1 Targeted Genome Analysis Kits Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Targeted Genome Analysis Kits Sales Mode & Process
  6. 9.2 Targeted Genome Analysis Kits Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Targeted Genome Analysis Kits Distributors
  9. 9.2.3 Targeted Genome Analysis Kits Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst